Prime Medicine (PRME) Non Operating Income (2021 - 2026)

Prime Medicine's Non Operating Income history runs 6 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Non Operating Income rose 205.18% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (up 88.38% YoY) and the FY2025 annual result came in at $7.2 million, up 9.46% from the prior year.
• Non Operating Income was $1.5 million for Q1 2026 at Prime Medicine, down from $2.5 million in the prior quarter.
• Across five years, Non Operating Income topped out at $3.4 million in Q3 2025 and bottomed at -$4.5 million in Q1 2022.
• A 5-year average of $910588.2 and a median of $1.5 million in 2026 frame the typical range for Non Operating Income.
• Peak annual rise in Non Operating Income reached 525.35% in 2024, while the deepest fall reached 92.73% in 2024.
• Prime Medicine's Non Operating Income stood at -$783000.0 in 2022, then jumped by 406.51% to $2.4 million in 2023, then retreated by 18.92% to $1.9 million in 2024, then increased by 29.96% to $2.5 million in 2025, then slumped by 39.42% to $1.5 million in 2026.
• Business Quant data shows PRME's Non Operating Income at $1.5 million in Q1 2026, $2.5 million in Q4 2025, and $3.4 million in Q3 2025.